Ietje Perfors

147 Table 1. Characteristics of all study participants at baseline andmissing study participants at T5. Intervention N = 77 Intervention missing T5 N = 18 (23%) Control N = 77 Control missing T5 N =8 (10%) Female n (%) 57 (74.0) 13 (72.2) 58 (75.3) 6 (75.0) Age mean (±SD) 61.8 (11.4) 64 (9.5) 59.3 (12.2) 62 (11.9) Cancer type N (%) Breast Colorectal Melanoma Gynaecologic Lung 38 (49.4) 20 (26.0) 13 (16.9) 3 (3.9) 3 (3.9) 8 (44.4) 6 (33.3) 2 (11.1) 2 (11.1) - 40 (51.9) 18 (23.4) 11 (14.3) 2 (2.6) 6 (7.8) 4 (50.0) 1 (12.5) 1 (12.5) 2 (25.0) - Hospital setting N (%) Academic Non academic 22 (28.6) 55 (71.4) 7 (38.9) 11 (61.1) 24 (31.2) 53 (68.8) 2 (25) 6 (75) Cancer stage 1 0 I II III IV 2 (2.6) 34 (44.2) 22 (28.6) 18 (23.4) 1 (1.3) - 6 (33.3) 5 (27.8) 6 (33.3) 1 (5.6) 2 (2.6) 34 (44.2) 27 (35.1) 14 (18.2) - - 5 (62.5) 3 (37.5) - - Education Low Middle High 32 (41.6) 13 (16.9) 32 (41.6) 9 (50) 1 (5.6) 8 (44.4) 25 (32.5) 18 (23.4) 34 (44.2) 1 (12.5) 4 (50.0) 3 (37.5) Number of comorbidities N (%) None >1 25 (32.5) 52 (67.5) 4 (22.2) 14 (77.8) 39 (50.6) 38 (49.4) 2 (25.0) 6 (75.0) Number of GP practice contacts (year prior inclusion) median (IQR) 7 (4.0;10.0) 7 (6.0;11.5) 6 (3.5;11.0) 9 (3.5;12.0) GP years of working experience median (IQR) 17 (12.0;25.5) 17 (11.8;21.0) 16 (10.5;24.5) 18 (13.0;26.0) GP setting N (%) Urban 2 Between rural and urban 3 Rural 4 51 (66.2) 14 (18.2) 12 (15.6) 10 (55.6) 3 (16.7) 5 (27.8) 45 (58.4) 15 (19.5) 17 (22.1) 6 (75.0) 2 (25.0) - 1 Stage based on TNM classifications, 2 1000 or more addresses per km^2, 3 1000-1500 addresses per km^2, 4 1000 or less addresses per km^2). Abbreviations: SD; Standard deviation, IQR; Inter quartile range. 6